Few participants had both a monogenic kidney disorder and a high-risk APOL1 genotype, with the majority being in type 4 collagen genes (5 CureGN participants, 1 Columbia-GN participant, and 6 Columbia-CKD participants; Supplemental Table 2). This evidence concerns the gene APOL1 and chronic kidney disease.